Fertility Infrastructure Stack
From at-home diagnostics to vertically integrated clinics, capital, and employer benefits.
Market opportunity$30.1B (2024) → $60.7B (2033)Global assisted reproductive technology (ART) market.Astute Analytica — Assisted Reproductive Technology Market Report ↗
The fertility ecosystem is consolidating around integrated care models combining diagnostics, clinical services, financing, and employer benefits. Retail distribution (Costco, Sesame) and public coverage expansion are pulling ART into the mainstream.
Fertility infrastructure is consolidating: clinics are vertically integrating diagnostics and care, while employer benefits are becoming a distribution channel of their own.
Egg-freezing volumes, employer adoption, and global public-coverage expansion (France, parts of the EU) are all pointing in the same direction — ART moving from niche to default.
Companies by infrastructure layer
Logos by layer. Click any company to open its verified profile.
Consumer-initiated hormone, microbiome, and cycle testing.
Cycle tracking, fertility prediction, and reproductive-health management at scale.
Signal · Flo Health surpassed 380M users; Natural Cycles is FDA-cleared digital contraception.
Fertility clinic networks and vertically integrated IVF providers.
Signal · Costco + Sesame + IVI RMA partnership signals retail-distribution moving into ART.
Employer-facing platforms managing fertility benefits and access.
Signal · Fertility benefits platforms raised $300M+ in 2024; 42% of U.S. employers offered fertility benefits in 2024 (up from 30% in 2020). Progyny investor relations ↗
Employer-sponsored fertility benefits, egg freezing, and family-forming coverage.
Signal · 60,000 employees used sponsored egg-freezing benefits in 2024; 45% of large U.S. employers offered IVF coverage in 2023.
Insurance, financing, and payment infrastructure for ART.
Signal · France expanded public ART coverage; U.S. employer coverage becoming standard for large employers.
Oocyte cryopreservation and egg-banking services.
Signal · 40,000+ egg-freezing cycles in U.S. (2023), up from 29,000 the prior year.
Male-factor diagnostics, sperm analysis, and cryobanking.
Next-generation therapeutics, automation, and AI for ART labs and clinics.
- 01Vertical integration
Clinics integrating with digital platforms, benefits, and financing into single bundles.
- 02Employer adoption
42% of U.S. employers offering fertility benefits in 2024 — fertility is now baseline at large employers.
- 03Retail distribution
Costco, Sesame partnerships bringing fertility care into mainstream retail channels.
- 04Financing expansion
Outcomes-based and lending products making ART more accessible.
- 05Global expansion
France and other countries expanding public ART coverage.
Companies marked “Verified source” link to a primary source (company release, SEC filing, peer-reviewed paper, or official agency page). “Press coverage” items are corroborated by reputable secondary outlets. “Source pending” items have not yet been independently re-verified at the link level.